Bolis G, Colombo N, Pecorelli S, Torri V, Marsoni S, Bonazzi C, Chiari S, Favalli G, Mangili G, Presti M

Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia Oncologica.

Ann Oncol 1995; 887-93. doi: 10.1093/oxfordjournals.annonc.a059355

Leggi ora
Pater JL, Zee B, Myles J, Pignon JP, Milan C, Sahmoud T, Torri V, Marsoni S

A proposal for a new approach to intergroup cancer trials.

Eur J Cancer 1995; 1921-3. doi: 10.1016/0959-8049(95)00433-5

Leggi ora
Bertolini G, Apolone G, Liberati A, Marsoni S, Scarpiglione N

[Comorbidity and the physician's decision: the case of undertreatment in care of breast tumors].

Epidemiol Prev 1994; 56-64.

Leggi ora
Marsoni S, Clerici M

Efficacy, semantic and chemotherapy in advanced NSCLC.

Ann Oncol 1994; 303-4. doi: 10.1093/oxfordjournals.annonc.a058828

Leggi ora
Kishan KV, Scita G, Wong WT, Di Fiore PP, Newcomer ME

The SH3 domain of Eps8 exists as a novel intertwined dimer.

Nat Struct Biol 1997; 739-43. doi: 10.1038/nsb0997-739

Leggi ora
Costanzo V

Brca2, Rad51 and Mre11: performing balancing acts on replication forks.

DNA Repair (Amst) 2011; 1060-5. doi: 10.1016/j.dnarep.2011.07.009

Leggi ora
Kotar J, Leoni M, Bassetti B, Lagomarsino MC, Cicuta P

Hydrodynamic synchronization of colloidal oscillators.

Proc Natl Acad Sci U S A 2010; 7669-73. doi: 10.1073/pnas.0912455107

Leggi ora
Clerici M, Panvini D, Torri V, Colombo F, Luporini G, Tinazzi A, Nicolucci A, Marsoni S

Patterns of care and survival in non small cell lung cancer: 15 years' experience in a general hospital.

Tumori 1994; 106-12. doi: 10.1177/030089169408000204

Leggi ora
Marsoni S, Torri W

Adjuvant chemotherapy for colon cancer: Italian studies.

Tumori 1997; S45-7.

Leggi ora
Marsoni S

Fluorouracil and folinic acid in colon cancer. IMPACT Investigators.

Lancet 1995; 1582-3.

Leggi ora
Darwiche N, Scita G, Jones C, Rutberg S, Greenwald E, Tennenbaum T, Collins SJ, De Luca LM, Yuspa SH

Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression.

Cancer Res 1996; 4942-9.

Leggi ora
De-Luca LM, Scita G

Ha-ras oncogene transformation abolishes retinoic acid-induced reduction of intracellular fibronectin.

Braz J Med Biol Res 1996; 1127-31.

Leggi ora
Piazza E, Donelli MG, Broggini M, Sessa C, Natale N, Ottolenghi L, Marsoni S, Libretti A, Mangioni C, Morasca L

Early phase pharmacokinetics of doxorubicin (adriamycin) in plasma of cancer patients during single- or multiple-drug therapy.

Cancer Treat Rep 1980; 845-54.

Leggi ora
Ottolenghi L, Morasca L, Marsoni S, Piazza E, Soresi E, Libretti A, Garattini S

Plasma levels of cyclophosphamide in patients under polychemotherapeutic regimens.

Biomedicine 1980; 123-7.

Leggi ora
Scita G, Darwiche N, Greenwald E, Rosenberg M, Politi K, De Luca LM

Retinoic acid down-regulation of fibronectin and retinoic acid receptor alpha proteins in NIH-3T3 cells. Blocks of this response by ras transformation.

J Biol Chem 1996; 6502-8. doi: 10.1074/jbc.271.11.6502

Leggi ora
Hashimoto Y, Costanzo V

Studying DNA replication fork stability in Xenopus egg extract.

Methods Mol Biol 2011; 437-45. doi: 10.1007/978-1-61779-129-1_25

Leggi ora
Marsoni S, Wittes R

Clinical development of anticancer agents--a National Cancer Institute perspective.

Cancer Treat Rep 1984; 77-85.

Leggi ora
O'Dwyer PJ, Shoemaker DD, Jayaram HN, Johns DG, Cooney DA, Marsoni S, Malspeis L, Plowman J, Davignon JP, Davis RD

Tiazofurin: a new antitumor agent.

Invest New Drugs 1984; 79-84. doi: 10.1007/BF00173791

Leggi ora
Shoemaker DD, O'Dwyer PJ, Marsoni S, Plowman J, Davignon JP, Davis RD

Spiromustine: a new agent entering clinical trials.

Invest New Drugs 1983; 303-8. doi: 10.1007/BF00177413

Leggi ora
Scita G, Wolf G

The effect of sphingosine on the release of fibronectin from human lung fibroblasts.

Biochim Biophys Acta 1994; 29-35. doi: 10.1016/0167-4889(94)90070-1

Leggi ora
O'Dwyer PJ, Alonso MT, Leyland-Jones B, Marsoni S

Teniposide: a review of 12 years of experience.

Cancer Treat Rep 1984; 1455-66.

Leggi ora
Hashimoto Y, Ray Chaudhuri A, Lopes M, Costanzo V

Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis.

Nat Struct Mol Biol 2010; 1305-11. doi: 10.1038/nsmb.1927

Leggi ora
Scita G, Wolf G

Retinoic acid and beta-carotene inhibit fibronectin synthesis and release by fibroblasts; antagonism to phorbol ester.

Carcinogenesis 1994; 1043-8. doi: 10.1093/carcin/15.5.1043

Leggi ora
Libretti A, Piazza E, Scanni A, Tomirotti M, Biraghi M, Scapaticci R, Bianchi C, Restelli G, Scarpazza G, Calzavara MP, Marsoni S, Morasca L

Bleomycin, vincristine, and methotrexate (BOM) in squamous cell carcinoma of the lung: a phase II study.

Cancer Treat Rep 1981; 171-2.

Leggi ora
Macdonald JS, Marsoni S, Bruno S, Poster D

Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin.

Recent Results Cancer Res 1982; 323-30. doi: 10.1007/978-3-642-81685-7_52

Leggi ora
Ottonello S, Scita G, Mantovani G, Cavazzini D, Rossi GL

Retinol bound to cellular retinol-binding protein is a substrate for cytosolic retinoic acid synthesis.

J Biol Chem 1993; 27133-42.

Leggi ora
Cosentino C, Grieco D, Costanzo V

ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair.

EMBO J 2011; 546-55. doi: 10.1038/emboj.2010.330

Leggi ora
Pisoni MB, Libretti A, Piazza E, Vago G, Scapaticci R, Bianchi C, Tomirotti M, Scanni A, Calzavara MP, Cassani L, Scarpazza G, Marsoni S, Morasca L

Phase II study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma.

Cancer Treat Rep 1981; 731-2.

Leggi ora
Ottolenghi I, Piazza E, Marsoni S, Trabattoni A, Natale N, Recchia M, Morasca L

Vincristine and bleomycin do not interfere with infusional plasma levels of methotrexate.

Eur J Cancer (1965) 1981; 365-6. doi: 10.1016/0014-2964(81)90129-8

Leggi ora
Poster DS, Penta J, Marsoni S, Bruno S, Macdonald JS

Bis-diketopiperazine derivatives in clinical oncology: ICRF-159.

Cancer Clin Trials 1980; 315-20.

Leggi ora
Morasca L, Marsoni S, Pisoni MB, Piazza E, Vago G, Casali W, Cogo R, Bianchi C, Scapaticci R

VP16-213 and cyclophosphamide in non oat cell bronchogenic carcinoma.

Cancer Chemother Pharmacol 1982; 209-10. doi: 10.1007/BF00254551

Leggi ora
Marsoni S

Dilemmas in the development of cytoxic drug analogues.

Eur J Cancer 1992; 1594-5. doi: 10.1016/0959-8049(92)90047-6

Leggi ora
Marsoni S, Valsecchi MG

Prognostic factors analysis in clinical oncology: handle with care.

Ann Oncol 1991; 245-7. doi: 10.1093/oxfordjournals.annonc.a057928

Leggi ora
Scheidl H, Scita G, Sampson PH, Park HY, Wolf G

The effect of sphingosine and phorbol ester on the signal transduction enzymes and fibronectin release in cell culture.

Biochim Biophys Acta 1992; 295-300. doi: 10.1016/0167-4889(92)90234-3

Leggi ora
Kagan VE, Serbinova EA, Forte T, Scita G, Packer L

Recycling of vitamin E in human low density lipoproteins.

J Lipid Res 1992; 385-97.

Leggi ora
Tsuchiya M, Scita G, Freisleben HJ, Kagan VE, Packer L

Antioxidant radical-scavenging activity of carotenoids and retinoids compared to alpha-tocopherol.

Methods Enzymol 1992; 460-72. doi: 10.1016/0076-6879(92)13148-q

Leggi ora
Arrigo C, Koier IJ, McVie JG, Marsoni S, Newlands E, Schwartsmann G

Minimal guidelines for the monitoring of early clinical trials (phase I-II) in Europe under CRC/EORTC/NCI joint agreement.

Eur J Cancer 1992; 1289-92.

Leggi ora
Scheidl H, Chandra T, Gmeiner B, Zerlauth G, Scita G, Wolf G

The effect of diacylglycerols on fibronectin release and its reversal by retinoic acid in cell culture.

Carcinogenesis 1991; 1791-4. doi: 10.1093/carcin/12.10.1791

Leggi ora
Sessa C, Colombo N, Bolis G, Marsoni S, Mangioni C

Randomized comparison of hexamethylmelamine, adriamycin, cyclophosphamide (HAC) vs. cisplatin, adriamycin, cyclophosphamide (PAC) in advanced ovarian cancer: long-term results.

Cancer Treat Rev 1991; 37-46. doi: 10.1016/0305-7372(91)90023-s

Leggi ora
%PLACEHOLDER%